Arkolith/Insider Trading/XERS/Form 4

Hecht Beth

See RemarksXeris Biopharma Holdings, Inc. (XERS) · full profile →Form 4 · filed Mar 21, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$217K
Net Open-Market Flow
-$217K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 20, 2025Sell(S)40K$5.43$217K1.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001867096-25-000047) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML